Inform future clinical development plans, further establishing elraglusib as a potential backbone therapy in difficult-to-treat cancersMechanisms of action support enhanced activity of GSK-3β plus RAS ...

The Phase 2b study to assess enobosarm’s ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients wi ...

EPA Region 8 is now accepting applications for the Wetland Program Development Grants. Apply on Grants.gov by April 20, 2026, at 9:59 P.M. MT ...

The Mortgage Industry Standards Maintenance Organization is nearing completion on the first of a three-phase Veterans Affairs loan guarantee modernization effort.

As drone threats reshape global warfare, India is accelerating the localisation of defence electronics. Check the four key players that are leveraging record order books in radar, avionics, and ...

Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...

The U.S. Department of Education is proposing to rework a decades-old program charged with helping states and school ...

Initial Phase 1 data of zovegalisib in PIK3CA-driven vascular anomalies expected to be announced in first half of 2026Breast cancer triplet data ...

NEWARK, CA / ACCESS Newswire / February 25, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the fourth quarter and full year ended ...

NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Two men from Pennsylvania admitted to repeatedly traveling from Philadelphia to Minneapolis in an effort to defraud Minnesota’s Housing Stabilization Services (HSS) program, prosecutors announced. The ...